Leukaemia is a malignant neoplasm of the haemato-poietic system. Cutaneous manifestations of leukaemia are called leukaemia cutis, and are regarded as a sign of poorer prognosis and shorter survival time. A single-institution retrospective review was performed of medical records of patients diagnosed with leukaemia cutis in the dermatology department of Seoul St Mary’s Hospital between January 2012 and April 2021. Fifty-six cases with cutaneous leukaemic involvement and underlying haematological malignancy were inclu-ded (40 acute myelogenous leukaemia, 8 acute lym-phoblastic leukaemia, 3 chronic myeloid leukaemia, 2 chronic lymphocytic leukaemia, and 3 myelodysplastic syndrome). Male-female ratio 1.9:1, mean age at diagnosis 45.8 years. Plaques (28%) and papules (27%) were the most common skin lesions, followed by pat-ches (18%) and nodules (16%). Mean time from diagnosis of leukaemia to development of leukaemia cutis was 12.3 months. Forty-six patients (84%) died during the 7-year follow-up; mean time from diagnosis of leukaemia cutis to death was 5.4 months. The results suggest that leukaemia cutis is associated with poor outcomes in patients with leukaemia. Comprehensive skin examination of these patients may help diagnose leukaemia cutis early, enabling prompt treatment.
CITATION STYLE
Yook, H. J., Son, J. H., Kim, Y. H., Han, J. H., Lee, J. H., Park, Y. M., … Bang, C. H. (2022). Leukaemia Cutis: Clinical Features and Outcomes of 56 Patients. Acta Dermato-Venereologica, 102. https://doi.org/10.2340/actadv.v102.1123
Mendeley helps you to discover research relevant for your work.